Haeggquist & Eck Announces Investigation of INSYS Therapeutics, Inc.

Haeggquist & Eck, LLP has commenced an investigation into possible violations of the federal securities laws by certain officers and directors at INSYS Therapeutics, Inc. (“Insys” or the “Company”) (NASDAQ: INSY). Insys is a specialty pharmaceutical [...]

By |2017-05-24T20:14:29+00:00June 30th, 2016|

Amber Eck and Alreen Haeggquist Receive “AV Preeminent” Ratings

Haeggquist & Eck partners Amber Eck and Alreen Haeggquist have received “AV Preeminent” ratings by research and lawyers’ information clearinghouse Martindale-Hubbell. AV Preeminent distinctions are the highest peer rating standard Martindale-Hubbell bestows on attorneys. The [...]

By |2017-05-24T20:14:43+00:00June 16th, 2016|